Protocol Ledger

NCT07214571 · Phase II · RECRUITING

A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Interventional Phase II clinical trial protocol NCT07214571 sponsored by Shionogi in Infectious Disease and Vaccines, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-12-11 Enrollment: 192 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07214571
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)192 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07214571
Protocol FieldVerified Registry Value
NCT IdentifierNCT07214571
Consolidated Lead SponsorShionogi
Therapeutic Condition CohortInfectious Disease and Vaccines
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment192 participants (ESTIMATED)
Registered Start Date2025-12-11
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Infectious Disease and Vaccines Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI